KI

Kazuhiro Ito

RE Respivert: 6 patents #2 of 28Top 8%
TL Topivert Pharma Limited: 1 patents #5 of 19Top 30%
Overall (2016): #18,998 of 481,213Top 4%
6
Patents 2016

Issued Patents 2016

Patent #TitleCo-InventorsDate
9475796 1-pyrazolyl-3-((4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitors Catherine Elisabeth Charron, John King-Underwood, Stuart Thomas Onions, Alistair Ian Longshaw 2016-10-25
9340545 Quinazolin-4 (3H)—one derivatives used as P13 kinase inhibitors John King-Underwood, Peter John Murray, George Hardy, Frederick Arthur Brookfield, Christopher John Brown 2016-05-17
9321773 Compounds John King-Underwood, Peter John Murray, George Hardy, Frederick Arthur Brookfield, Christopher John Brown 2016-04-26
9260410 P38 MAP kinase inhibitors John King-Underwood, Peter Strong, William Garth Rapeport, Catherine Elisabeth Charron, Peter John Murray +2 more 2016-02-16
9249125 Pyrazole derivatives as p38 MAP inhibitors Lorna Duffy, John King-Underwood, Alistair Ian Longshaw, Peter John Murray, Stuart Thomas Onions +3 more 2016-02-02
9242960 P38MAP kinase inhibitors Peter Strong, William Garth Rapeport, Peter John Murray, John King-Underwood, Jonathan Gareth Williams +2 more 2016-01-26